Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?
Bicycle Therapeutics Ownership Summary
Bicycle Therapeutics is owned by 3.22% institutional investors, 4.42% insiders, and 92.36% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 15.71% of BCYC shares. Westfield Capital Mgt Co Sm-Cap Gr Eq is the top mutual fund, with 1.47% of its assets in Bicycle Therapeutics shares.
BCYC Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bicycle Therapeutics | 3.22% | 4.42% | 92.36% |
| Sector | Healthcare Stocks | 35.49% | 11.78% | 52.72% |
| Industry | Biotech Stocks | 34.84% | 11.71% | 53.45% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Baker bros. advisors lp | 10.89M | 15.71% | $50.51M |
| Fcpm iii services b.v. | 3.47M | 5.01% | $16.09M |
| Armistice capital | 3.40M | 4.90% | $15.77M |
| Long focus capital management | 3.31M | 4.78% | $15.36M |
| Acadian asset management | 1.97M | 2.84% | $9.11M |
| Siren | 1.56M | 2.25% | $7.24M |
| Gsk | 1.53M | 2.21% | $7.10M |
| Principal financial group | 1.17M | 1.70% | $5.45M |
| Price t rowe associates inc /md/ | 1.03M | 1.48% | $4.77M |
| Renaissance | 979.30K | 1.41% | $4.54M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Aquilo capital management | 171.69K | 2.61% | $1.46M |
| Fcpm iii services b.v. | 3.47M | 2.23% | $16.09M |
| Birchview capital, lp | 463.60K | 1.22% | $2.15M |
| Gsk | 1.53M | 1.18% | $7.10M |
| Rangeley capital | 232.26K | 1.05% | $1.08M |
| Peapod lane capital | 121.11K | 0.45% | $550.21K |
| Long focus capital management | 3.31M | 0.40% | $15.36M |
| Diadema partners lp | 476.42K | 0.38% | $2.21M |
| Baker bros. advisors lp | 10.89M | 0.29% | $50.51M |
| Armistice capital | 3.40M | 0.28% | $15.77M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Long focus capital management | 3.31M | 0.40% | 1.68M |
| Diadema partners lp | 476.42K | 0.38% | 476.42K |
| Renaissance | 979.30K | 0.01% | 412.70K |
| Marshall wace, llp | 377.33K | 0.00% | 338.54K |
| Qube research | 308.62K | 0.00% | 308.62K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Paradigm biocapital advisors lp | - | - | -3.25M |
| Westfield capital management co lp | - | - | -3.02M |
| Deep track capital, lp | - | - | -1.20M |
| Candriam s.c.a. | - | - | -1.19M |
| Ra capital management | - | - | -1.09M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Diadema partners lp | 476.42K | 0.38% | 476.42K | $2.21M |
| Qube research | 308.62K | 0.00% | 308.62K | $1.43M |
| Peapod lane capital | 121.11K | 0.45% | 121.11K | $550.21K |
| Persistent asset partners | 120.44K | 0.21% | 120.44K | $558.83K |
| Entrypoint capital | 63.91K | 0.09% | 63.91K | $296.52K |
Sold Out
| Holder | Change |
|---|---|
| Zurcher kantonalbank (zurich cantonalbank) | -4.00 |
| Northwestern mutual wealth management | -5.00 |
| Mather group, llc. | -5.00 |
| Eversource wealth advisors | -6.00 |
| Steward partners investment advisory | -10.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 36 | -68.70% | 2,227,370 | -94.31% | 3 | 0.10% | 20 | -64.91% | 6 | -79.31% |
| Dec 31, 2025 | 68 | -33.98% | 13,199,592 | -64.23% | 19 | 0.67% | 32 | -34.69% | 19 | -17.39% |
| Sep 30, 2025 | 94 | -16.07% | 32,600,347 | -18.41% | 47 | 1.41% | 46 | -26.98% | 20 | -4.76% |
| Jun 30, 2025 | 115 | 18.56% | 41,177,900 | -1.34% | 59 | 1.63% | 66 | 53.49% | 21 | -30.00% |
| Mar 31, 2025 | 1 | -99.00% | 68,943 | -99.84% | - | 0.00% | - | -100.00% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Westfield Capital Mgt Co Sm-Cap Gr Eq | 1.02M | 1.47% | 30.53K |
| Harbor Small Cap Growth Instl | 1.02M | 1.47% | 30.53K |
| Candriam Eqs L Biotech C USD Cap | 825.13K | 1.19% | 19.89K |
| T. Rowe Price Health Sciences | 739.25K | 1.06% | -55.22K |
| International Biotechnology Ord | 615.83K | 0.88% | 31.06K |
| BNP Paribas Health Cr Innovtr Cl Cap | 568.51K | 0.82% | 568.51K |
| Principal U.S. Small Cap Equity | 523.30K | 0.75% | -44.50K |
| Principal U.S. Small Cap Select Equity | 523.30K | 0.75% | -44.50K |
| Principal SmallCap R5 | 523.30K | 0.75% | -19.50K |
| Candriam Global Equities Oncology | 492.11K | 0.71% | 125.18K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 02, 2026 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | $7.47K |
| Apr 06, 2026 | Hannay Michael Charles Ferguson | CHIEF PROD & SUPPLY CHAIN OFF | Sell | $1.27K |
| Apr 06, 2026 | Thompson Travis Alvin | Chief Financial Officer | Sell | $515.10 |
| Apr 02, 2026 | Thompson Travis Alvin | Chief Financial Officer | Sell | $3.92K |
| Apr 02, 2026 | Perry Jennifer Scott | Chief Operating Officer | Sell | $5.10K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 11 |
| 2026 Q1 | - | 13 |
| 2025 Q4 | - | 13 |
| 2025 Q3 | - | 11 |
| 2025 Q2 | - | 11 |
BCYC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools